STOCK TITAN

Fortrea to Present at the Jefferies Global Healthcare Conference

Fortrea (FTRE), a global contract research organization (CRO), announced that Chairman and Interim CEO Peter M. Neupert and CFO Jill McConnell will present at the Jefferies Global Healthcare Conference on June 5, 2025, at 8:45 am ET.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences
Fortrea (FTRE), a global contract research organization (CRO), announced that Chairman and Interim CEO Peter M. Neupert and CFO Jill McConnell will present at the Jefferies Global Healthcare Conference on June 5, 2025, at 8:45 am ET. Investors can access the live webcast through Fortrea's Investor Relations website, with a replay available after the event. The presentation represents an opportunity for the company to share updates and insights with the investment community.
Loading...
Loading translation...
Argus Session date unavailable
+12.96% session move Open Argus
Details

News Market Reaction – FTRE

The recorded move for FTRE in the trading session of this news was +12.96%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

DURHAM, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Interim Chief Executive Officer, Peter M. Neupert and Chief Financial Officer, Jill McConnell will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025 at 8:45 am ET.

The live webcast will be available to investors and other interested parties by accessing the Fortrea Investor Relations website. A webcast replay will be available after the event.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).

Fortrea Contacts:

Hima Inguva (Investors) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Fortrea (FTRE) presenting at the Jefferies Healthcare Conference 2025?

Fortrea will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025 at 8:45 am ET.

Who will represent Fortrea (FTRE) at the Jefferies Healthcare Conference?

Chairman and Interim CEO Peter M. Neupert and CFO Jill McConnell will represent Fortrea at the conference.

How can investors watch Fortrea's presentation at the Jefferies Conference?

Investors can watch the live webcast through Fortrea's Investor Relations website, with a replay available after the event.

What type of company is Fortrea (FTRE)?

Fortrea is a leading global contract research organization (CRO).

Keep reading